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Abstract
Cure models in survival analysis deal with populations in which a part of the
individuals cannot experience the event of interest. Mixture cure models consider
the target population as a mixture of susceptible and non-susceptible individuals.
The statistical analysis of these models focuses on examining the probability of cure
(incidence model) and inferring on the time-to-event in the susceptible subpopulation
(latency model).
Bayesian inference on mixture cure models has typically relied upon Markov chain
Monte Carlo (MCMC) methods. The integrated nested Laplace approximation (INLA)
is a recent and attractive approach for doing Bayesian inference. INLA in its natural
definition cannot fit mixture models but recent research has new proposals that
combine INLA and MCMC methods to extend its applicability to them2;8;9.
This paper focuses on the implementation of INLA in mixture cure models. A
general mixture cure survival model with covariate information for the latency and
the incidence model within a general scenario with censored and non-censored
information is discussed. The fact that non-censored individuals undoubtedly belong
to the uncured population is a valuable information that was incorporated in the
inferential process.
Keywords
Accelerated failure time mixture cure models, Complete and marginal likelihood
function, Gibbs sampling, Proportional hazards mixture cure models, Survival
analysis
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Introduction
Survival analysis is an area of statistics dedicated to researching time-to-event data.
This is one of the oldest areas of statistics, which dates back to the 1600s with the
construction of life tables. The study of time-to-event data seems simple and traditional
because its main focus is centered on non-negative random variables. But this is very
far from being the case. The fact that survival times are always positive keeps it away
from the normal distribution framework, censoring and truncation schemes produce non-
traditional likelihood issues, and the special elements that generate the dynamic nature
of events occurring in time make survival analysis an interesting and exciting area of
research and application, mainly in the biomedical field.
Cure models in survival analysis deal with target populations in which a part of the
individuals cannot experience the event of interest. This type of models have largely
been developed as a consequence of the discovery and development of new treatments
against cancer. The rationale of considering a cure subpopulation comes from the idea
that a successful treatment removes totally the original tumor and the individual cannot
experience any recurrence of the disease. These models allow to estimate the probability
of cure, a key and valuable outcome in cancer research. This is not the case for the
traditional survival models which consider that all the individuals in the population are
at risk. As stated by15, it is important to bear in mind that cure is considered from a
statistical, population point of view and not from an individual perspective.
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Mixture cure models are the most popular cure models. They consider that the
target population is a mixture of susceptible and non-susceptible individuals. The main
interest focuses on the so called incidence model, that accounts for the probability of
cure, and the latency model for the time-to-event in the susceptible subpopulation. A
mixture model such as this is very attractive, easy to interpret, and allows to account for
model complexity (frailties, time-dependent covariates, etc) in both incidence and latency
terms22. Some studies in cancer research with this type of models are31 who discussed
data from trials in paediatric cancer conducted by the Children’s Cancer Group,26 who
studied recurrences for breast cancer and readmissions for colorectal cancer, and11 who
centered on melanoma cancer. A very interesting review of these models up to date is22.
Cured models also appear in other areas of research. This is the case of split population
models in economics30 and limited-failure population life models in reliability21.
Bayesian inference always expresses uncertainty in terms of probability distribu-
tions17;18 and uses Bayes’ theorem as often as necessary in a sequential way to update
all relevant information. Bayesian methodology is especially attractive for survival
analysis due to its natural treatment of censoring and truncation schemes as well as the
probabilistic quantification of relevant survival outcomes, such as survival probabilities,
that they do not need to resort to asymptotic tools12.
Computation in Bayesian inference is a key issue that allows the approximate
implementation of non-analytical posterior distributions. The integrated nested Laplace
approximation (INLA)28 is a recent methodology for doing approximate Bayesian
inference in the framework of latent Gaussian models (LGM)27. These models are
a special class of Bayesian additive models that cover a wide range of studies and
applications29, and survival models in particular20. INLA, in comparison to Markov
chain Monte Carlo (MCMC) methods, provides accurate and fast approximations to the
relevant posterior marginal distributions.
INLA is very attractive and has very good properties but it also has some limitations.
In particular, INLA cannot fit mixture models19 in a natural way because they are
generally defined in terms of a combination of different distributions9. But in science,
every constraint or difficulty becomes an opportunity for learning. On this matter,2 and9
propose the combination of INLA within MCMC for mixture models, in particular Gibbs
sampling, and fit with INLA the relevant posterior conditional distributions.8 extends
these proposals and introduce Modal Gibbs sampling to accelerate the inferential process.
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This paper focuses on the implementation of INLA in mixture cure models. A
general mixture cure survival model with covariate information for the latency and the
incidence model within a general scenario with censored and non-censored information
is discussed. The fact that non-censored individuals undoubtedly belong to the uncured
population is a valuable information that was incorporated in the inferential process.
The organization of this paper is as follows. Section 2 presents the main elements of
mixture cure models and the two most popular mixture cure models, the Cox proportional
hazards and the accelerated failure times models. Section 3 introduces the integrated
nested Laplace approximation within the general framework of Bayesian inference.
Section 4 is the core of the paper and contains our INLA proposal for estimating mixture
cure models. Section 5 applies our proposal to the statistical analysis of two benchmark
data sets in the framework of clinical trials and bone marrow transplants, and discusses
and compares the subsequent results with those from a MCMC implementation. The
paper ends with some conclusions.
Mixture cure models
Let T ∗ be a continuous and non-negative random variable that describes the time-to-event
of an individual in some target population. Let Z be a cure random variable defined as
Z = 0 if that individual is susceptible for experiencing the event of interest, and Z = 1
if she/he is cured or immune for that event. Cure and non cure probabilities are P (Z =
1) = η and P (Z = 0) = 1− η, respectively. The survival function for individuals in the
cured and uncured population, Sc(t) and Su(t), t > 0, respectively, is
Su(t) = P (T
∗ > t | Z = 0)
Sc(t) = P (T
∗ > t | Z = 1) = 1. (1)
The general survival function for T ∗ can be expressed in terms of a mixture of both cured
and uncured populations in the form
S(t) = P (T ∗ > t) = η + (1− η)Su(t). (2)
It is important to point out that Su(t) is a proper survival function but S(t) is not. It goes
to η and not to zero when t goes to infinity. Cure fraction η is also known as the incidence
model and time-to-event T ∗u in the uncured population as the latency model
22.
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Covariates in the incidence model
The effect of a baseline covariate vector x1 on the cure proportion is typically modeled
by means of a logistic link function, logit[η(β1)] = β
′
1x1, also expressed as
η(β1) =
exp{β′1x1}
1 + exp{β′1x1}
, (3)
where β1 is the vector of regression coefficients associated to x1. Note that other link
functions can be used to connect the cure fraction with the vector of covariates x1 such
as the probit link or the complementary log-log link (see25 for more details).
Covariates in the latency model
The most common regression models in survival analysis are the Cox proportional
hazards model5 and the accelerated failure time models. We will introduce them below.
Cox proportional hazards model, CPH. It is usually formulated in terms of the hazard
function for the time-to-event T ∗u , or instantaneous rate of occurrence of the event, as
hu(t | hu0,β2) = lim
∆t→∞
P (t ≤ T ∗u < t+ ∆t | T ≥ t)
∆t
= hu0(t) exp{β′2x2}, (4)
where hu0(t) is the baseline hazard function that determines the shape of the hazard
function. Model (4) can also be presented in terms of the survival function of T ∗u as
Su(t | Su0,β2) = [Su0(t)]exp{β
′
2x2}, (5)
where Su0(t) = exp{−
∫ t
0
hu0(s)ds} represents the survival baseline function.
Fully Bayesian methods specify a model for hu0(t) which may be of parametric
or non-parametric nature. Exponential, Weibull and Gompertz hazard functions are
common parametric proposals in the empirical literature. Mixture of piecewise constant
functions or B-splines basis functions are the usual counterpart in non-parametric
selections. They provide a great flexibility to the modeling by allowing different
patterns and multimodalities but some care is needed when working with them to avoid
overfitting. To this effect, the elicitation of prior distributions is a relevant issue in the
Bayesian approach to regularization16.
Accelerated failure time models, AFT. These models try to adapt the philosophy of
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linear models to the survival framework. The survival variable T ∗u is now expressed in
the logarithmic scale to extend the modeling to the real line. It is modeled as the sum of
a linear term for the covariates x2, which usually includes an intercept element, and a
random error  amplified or reduced by a scale factor σ as followss
log(T ∗u ) = x
′
2β2 + σ. (6)
Common distributions for  are normal, logistic and standard Gumbel. They respectively
imply log-normal, log-logistic and Weibull distributions for T ∗u
4. Weibull AFT models
are the most popular ones, in which covariates x2 are commonly included in the scale
parameter as λ(β2) = exp{β′2x2}, and consequently
hu(t | α,β2) = α tα−1 exp{β′x2},
Su(t | α,β2) = exp{−tαe{β
′
2x2}}. (7)
This modeling strategy based on introducing covariate information through one of the
parameters of the target distribution also applies to the rest of parametric probability
distributions.
Bayesian inference and the integrated nested Laplace
approximation
Bayesian inference derives the posterior distribution of the quantities of interest
according to Bayes’ theorem, which combines the prior distribution of all unknown
quantities and the likelihood function constructed from the data. It is the main element in
Bayesian statistics and starting point of all relevant inferences. The posterior distribution
in complex models is non analytical and for this reason it needs to be computationally
approached. To that effect, MCMC methods are surely the most popular procedures
although they involve large computational costs and require additional work for checking
convergence and accuracy estimation.
The structure and main elements of the INLA approach for doing Bayesian inference
are summarised below. Let us assume a set of n random variables T ∗ = (T ∗1 , . . . , T
∗
n)
mutually conditionally independent given a latent Gaussian Markov random field
(GMRF)27 θ and a set of likelihood hyperparameters φ2. The GMRF θ depends on some
hyperparameters φ1 and can include effects of different type (regression coefficients,
random effects, seasonal effects, etc).
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According to Bayes’ theorem, the joint posterior distribution for (θ,φ), where φ =
(φ1,φ2), after dataD = ∪ni=1Di have been observed, whereDi represents the data from
individual ith, can be written as
pi(θ,φ | D) ∝ ∏ni=1 Li(θ,φ | D)pi(θ,φ)
∝ ∏ni=1 Li(θ,φ | D)pi(θ | φ)pi(φ), (8)
where Li(θ,φ | D) is the likelihood function of (θ,φ) for data Di, and pi(θ,φ)
represents the prior distribution of (θ,φ) which factorizes as the product of a GMRF
conditional prior distribution pi(θ | φ) and a marginal prior distribution pi(φ).
INLA makes use of Laplace approximations28 to obtain approximations p˜i(φ | D) and
p˜i(θ· | φ,D) for the posterior distribution pi(φ | D) and pi(θ· | φ,D), respectively, where
θ· denotes a generic univariate element in θ. The marginal posterior distribution for the
latent terms pi(θ· | D) can be obtained as
pi(θ· | D) = ∫ pi(θ· | φ,D)pi(φ | D) dφ, (9)
and consequently, it can be approximated by numerical integration as
p˜i(θ· | D) ≈
∑
m
p˜i(θ· | φm,D) p˜i(φm | D) ∆m, (10)
where φm are points in the hyperparametric space Φ, and ∆m integration weights.
The posterior marginal distribution pi(φ·|D′) can also be approximated by numerical
integration according to the expression
pi(φ· | D) = ∫ pi(φ | D) dφ−·, (11)
where φ−· represents all elements in φ except φ·.
INLA is implemented in the package R-inla for the R statistical software24. This
package implements a number of latent effects and allows for an easy model fitting and
visualization of the output. A recent review on INLA and the can be found in29.
INLA to estimate mixture cure models
In general, standard survival models such as CPH and AFT models can be expressed
in terms of GMRF models, and consequently they can be adapted for its INLA
implementation1;20. In the case of CPH models, the baseline hazard function is
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reparameterized in the exponential scale in order to be included in the CPH element
that accounts for regression information. This exponential term also allows the inclusion
of time-varying covariate effects, nonlinear, structured or non random effects, spatial
modelling, etc10. They can be expressed by means of a structured geoadditive predictor
whose elements can be modeled in terms of a GMRF model. AFT models also have this
nice relationship and behaviour for INLA implementation.
Gibbs sampler for mixture estimation
Let us consider a general survival scenario in the framework of non-informative and
independent right censoring and a mixed cure sampling model. Survival time is defined
as the pair (T, δ), where T = min(T ∗, C),C being the censoring time, and δ an indicator
function defined as δ = 0 when the subsequent observation is censored (T ∗ > C), and
δ = 1 when it is not. We assume that the distribution of T ∗ depends on a conditional
GRMF θ on hyperparameters φ1 and a likelihood hyperparametric vector φ2, and
consider pi(θ,φ) as the prior distribution for (θ,φ) which factorizes as
pi(θ,φ) = pi(θ | φ)pi(φ). (12)
Let Di = (ti, δi) represent the survival observed data for individual i, i = 1, . . . , n, and
D = ∪ni=1Di. The complete data for individual i is defined as Dcom,i = (ti, δi, zi) =
(Di, zi), which includes the value zi of the subsequent latent variable that classifies this
individual as cured or not, and Dcom = ∪ni=1Dcom,i. It should be noted that an observed
survival time clearly indicates that the subsequent individual belongs to the uncured
population.
The complete data likelihood function is the product of the complete likelihood
function for each individual defined as12
L(θ,φ | Dcom) =
=
∏n
i=1 Li(θ,φ | Dcom)
=
∏n
i=1 ηi(θ,φ)
zi (1− ηi(θ,φ))1−zi hiu(ti | θ,φ)δi (1−zi) Siu(ti | θ,φ)(1−zi).
(13)
As z is seldom observed, it is often treated as another parameter in the model and its
posterior distribution needs to be computed as well. The posterior distribution for (θ,φ)
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computed from Bayes’ theorem would be
pi(θ,φ | D) ∝ L(θ,φ | D)pi(θ,φ)
∝∑z∈Z L(θ,φ | D, z)pi(θ,φ),
where L(θ,φ | D) is the likelihood function of (θ,φ) for the observed data D, and Z
denotes the parameter space of the cure indicator values, which is the n-dimensional
Cartesian product of the binary set {0, 1}.
The introduction of the latent indicator in the inferential process and the Gibbs sampler
is the usual procedure to approach Bayesian mixture estimation6;19. We follow this
proposal and consider the inferential process defined by the joint posterior distribution
pi(θ,φ, z | D) ∝ L(θ,φ | Dcom)pi(θ,φ),
and a Gibbs sampler based on the full conditional posterior distributions pi(θ,φ | z,D)
and pi(z | θ,φ,D).
INLA and modal Gibbs
Our proposal for fitting mixture cure models by means of INLA is based on9 and8, who
use INLA for estimating the conditional posterior marginals of the model parameters
pi(θ· | D, z) and pi(φ· | D, z), which assumes that the latent vectors which determine
the subpopulation to which each individual belongs to are known. All relevant marginal
posterior distributions, pi(θ· | Dcom) and pi(φ· | Dcom), can be fitted as usual in the
INLA approach.
The posterior marginal distribution for each θ· can be computed as
pi(θ· | D) =
∑
z∈Z
pi(θ·, z | D)
=
∑
z∈Z
pi(θ· | z,D)pi(z | D)
=
∑
z∈Z
pi(θ· | Dcom)pi(z | D), (14)
where pi(θ· | z,D) is fitted by INLA and pi(z | D) is the marginal posterior distribution
for the latent cure indicator vector based on the observed data. This latter distribution
will be computed using modal Gibbs sampling as proposed by8. The computation of
pi(φ· | D) follows a similar procedure.
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Expression (14) needs some additional discussion so that it can be better adapted
to the cure models framework. Here, we know that each survival observation can be
censored or uncensored. In the case of a censored data, we do not know if the subsequent
individual can or cannot experience the event of interest, hence their belonging to the
uncured or cured subpopulation is unknown and consequently, there will be uncertainty
about the value of the corresponding cure indicator variable. Conversely, an uncensored
observation will indicate that the subsequent individual has surely experienced the event
of interest, and therefore she/he belongs to the uncured subpopulation. If we split
z = (zunc, zcen), where zunc (zcen) represents the nunc (ncen)-dimensional latent cure
indicator corresponding to the uncensored (censored) data, the complete knowledge on
the value of the latent indicator of the uncensored data will imply zunc = 0. For this
reason,
pi(z | D) = pi(zunc, zcen | D) =
pi(zcen | D) for zunc = 0, zcen ∈ Zcen0 otherwise,
where now Zcen is the parameter space of the cure indicator variables for the censored
observations, with lower dimensionality than Z . Hence, expression (14) can be rewritten
as
pi(θ· | D) =
∑
zcen∈Zcen
pi(θ· | Dcom)pi(zcen | D). (15)
The above procedure can be described in a more structured way via the following
algorithm:
Step 0. Assign initial values to the latent cure indicator of the ncen censored
observations, z(0)cen, and consider zunc = 0 for the uncensored observations.
Define z(0) = {z(0)cen, zunc}.
Step 1. For m = 1, 2, . . .
(a) Use INLA to approximate pi(θ· | z(m−1),D) and pi(φ· | z(m−1),D).
(b) Compute the subsequent posterior (conditional) modes θˆ(m)· and φˆ(m)· ,
respectively, from each of the posterior distributions in (a).
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(b) Sample z(m)cen = (z
(m)
cen,1, . . . , z
(m)
cen,ncen) from the full conditional distribution
for the cure latent variable3;19
pi(Z = 0 | D, θˆ(m), φˆ(m)) =
=
(1− ηc(θˆ(m), φˆ(m))Scu(tc | θˆ(m), φˆ(m))
ηc(θˆ
(m)
, φˆ
(m)
) + (1− ηc(θˆ(m), φˆ(m)))Scu(tc | θˆ(m), φˆ(m))
,
pi(Z = 1 | D, θˆ(m), φˆ(m)) = 1− pi(Z = 0 | D, θˆ(m)).
(d) Define z(m) = {z(m)cen , zunc}.
Illustrative studies
We considered two benchmark datasets to illustrate our proposal for estimating mixture
cure models via INLA. They are the so-called Eastern Cooperative Oncology Group
(ECOG) phase III clinical trial e1684 dataset14 and the bonemarrow transplant study
dataset13. In both studies, we compared our results with the ones obtained via MCMC
methods. Inferences in both studies were performed on a Windows laptop with an
Intel(R) Core(TM) i7-7700 3.60GHz processor. All implementations were made in the R
environment (version 3.4.3). We used the R-INLA package for INLA and JAGS software
(version 4.3.0) through the rjags package23 for MCMC inferences.
ECOG study
The ECOG phase III clinical trial was designed to compare a high dose interferon alpha-
2b (IFN ) regimen against close observation which was the standard therapy (ST ) as the
postoperative adjuvant treatment14 in high-risk melanoma patients. Data in the analysis
included a total of 284 observations, of which 88 were right-censored. Relapse-free
survival (FFS), in years, was one of variables of interest in the study and now our survival
variable. Covariate information included gender, 113 women (W ) and 171 men (M ),
treatment (144 people in the IFN group and 140 in ST ), and age (A) (in years and
centered on the sample mean). FFS sample median was 1.24 and 1.36 years in the case
of M and W , and 1.82 and 0.98 years in the IFN group and ST , respectively.
Incidence and latency model. We considered the same CPH mixture cure model stated
by the authors in14. The cure proportion for individual ith in the incidence model was
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expressed in terms of a binary regression logistic model defined as
logit[ηi(β1)] = β0,1 + βW,1 IW (i) + βIFN,1 IIFN (i) + βA,1Ai, (16)
where β0,1 represents the reference category, to be a man receiving ST treatment, and
IG(i) is an indicator variable with value 1 if individual i has the characteristic G and 0
otherwise.
Survival time for individual i the uncured subpopulation was modeled by a CPH model
with hazard function,
hui(t | hu0,β2) = hu0(t) exp{β0,2 + βW,2 IW (i) + βIFN,2 IIFN (i) + βA,2Ai},
(17)
with Weibull baseline hazard function hu0(t) = αtα−1.
The model is completed with the elicitation of a prior distribution for all uncertainties
it includes. We assume prior independence and select vague normal distributions centered
at zero and variance 1,000 for all the regression coefficients in (16) and (17) as well as
for log(λ). The elicited prior distribution for α is the gamma distribution Ga(0.01, 0.01),
a very common election in these models which baseline hazard function is specified in
terms of a Weibull distribution.
Posterior inferences Our algorithm configuration included 50 burn-iterations followed
by other 450 iterations for inference. In addition, the simulations were thinned by storing
one in five draws in order to reduce autocorrelation in the saved sample. The convergence
was evaluated by examining whether the estimated conditional (on z) marginal log-
likelihood achieved stability during the iteration steps of the algorithm.
INLA results were compared to those obtained via MCMC methods with the JAGS
software. A MCMC algorithm was run considering three Markov chains with 100,000
iterations each and a burn-in period with 20,000 ones. In addition, the chains were
thinned by storing one in two hundred iterations in order to reduce autocorrelation in
the saved sample and avoid space computer problems. Convergence was assessed based
on the potential scale reduction factor and the effective number of independent simulation
draws7.
The number of iterations needed to accomplish convergence under our proposal is a
fraction than the one in the MCMC configuration. This occurs because our algorithm
only needs to explore the parameter space of the cure indicator variables corresponding
to the censored observations, Zcen, and not the full parameter space Z . Futhermore, the
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Table 1. Summary of the INLA and MCMC approximate marginal posterior distributions:
mean, standard deviation, 95% credible interval, and posterior probability that the subsequent
parameter is positive.
Parameter Mean Sd 95 %CI P (· > 0)
Incidence INLA β0,1 -1.200 0.235 [-1.676,-0.753] 0.000
βW,1 0.061 0.275 [-0.483,0.597] 0.587
βIFN,1 0.573 0.271 [0.045,1.107] 0.983
βA,1 -0.015 0.010 [-0.035,0.005] 0.076
MCMC β0,1 -1.220 0.239 [-1.701,-0.777] 0.000
βW,1 0.058 0.283 [-0.518,0.595] 0.585
βIFN,1 0.573 0.271 [0.045,1.107] 0.983
βA,1 -0.015 0.010 [-0.035,0.005] 0.076
Latency INLA α 0.918 0.052 [0.818,1.022] −
exp{β0,2} 0.938 0.113 [0.729,1.173] −
βW,2 0.131 0.161 [-0.187,0.442] 0.794
βIFN,2 -0.106 0.154 [-0.410,0.195] 0.244
βA,2 -0.007 0.005 [-0.018,0.004] 0.098
MCMC α 0.909 0.055 [0.802,1.016] −
exp{β0,2} 0.921 0.114 [0.715,1.152] −
βW,2 0.133 0.168 [-0.201,0.437] 0.779
βIFN,2 -0.108 0.165 [-0.441,0.209] 0.269
βA,2 -0.007 0.006 [-0.018,0.003] 0.102
parameters space of model parameters (θ,φ) is not explored as their posterior marginals
are computed from the conditional posterior marginals obtained with INLA.
Table 1 shows a summary of the INLA and MCMC approximate posterior marginal
distribution of the parameters of the mixture cure model estimated. The agreement in
all the outputs is quite high and confirms that our approach works and provides similar
estimates to MCMC.
The estimation of the cure proportion as well as the survival profiles for the
different groups of individuals are relevant issues in the medical context of the
study. INLA computes an approximation to the conditional marginal log-likelihood
function pi(D|z) and it can be used to select the most likely configuration of the
latent vector z that has been generated during the sample process to approximate the
posterior distribution of the cure proportion and the survival profiles. In particular,
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the inla.posterior.samples function in the R-INLA package may be used to
generate samples from the approximated joint posterior distribution of the estimated
model (we select the most likely model). Additionally, these samples can subsequently
be processed to derive approximated posterior distributions for the quantities of interest.
Table 2. Summary of the approximated INLA and MCMC posterior mean, standard deviation,
and 95% credible interval of the cure proportion for averaged age individuals in the four
groups of the study.
Group Mean Sd 95 %CI
INLA M-ST 0.242 0.042 [0.166, 0.333]
M-IFN 0.363 0.046 [0.280, 0.453]
W-ST 0.258 0.048 [0.172, 0.357]
W-IFN 0.382 0.056 [0.278, 0.495]
MCMC M-ST 0.231 0.042 [0.230, 0.315]
M-IFN 0.345 0.048 [0.252, 0.443]
W-ST 0.242 0.049 [0.151, 0.346]
W-IFN 0.358 0.057 [0.248, 0.475]
Table 2 includes the INLA and MCMC posterior mean, standard deviation and 95%
credible interval of the posterior distribution of the cure proportion for individuals in the
four groups of interest: men treated with the standard therapy (M-ST), men treated with
interferon alpha-2b (M-IFN), women in the standard therapy group (W-ST), and IFN
women (W-IFN). Outcomes from INLA and MCMC also are in close agreement and
highlight that (W-IFN) individuals present the highest cure proportion estimates while
the lowest values correspond to M-ST ones. Differences between treatments are clinically
relevant for both women and men.
Figure 1 displays the INLA and MCMC mean of the posterior distribution of the
uncured survival function for individuals in each of the four groups of interest. Estimation
from both approaches scarcely differs. From a clinical point of view, the survival
profiles are very similar among the groups, but it seems that the best and worst survival
expectations correspond to M-IFN and W-ST groups, respectively. We could conclude
that the probability of cure is very different among the groups (see Table 2) but the
uncured survival profiles of the individuals in the different groups are very similar (see
Figure 1).
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Figure 1. Posterior mean of the uncured survival function for individuals in the groups
M-ST (on the top left), M-IFN (on the top right), W-ST (at the bottom left), and W-IFN (at the
bottom right) computed with INLA (black solid line) and MCMC (red dashed line).
Bone marrow transplant study
Next, we consider the bone marrow transplant study dataset in13 to illustrate our proposal
for a Weibull AFTMC model. This study was undertaken to compare autologous and
allogeneic marrow transplantation with regard to survival times of patients affected
with lymphoblastic leukemia and poor prognosis. A total of 91 patients were treated
with high-doses of chemoradiotherapy and followed-up during a period between 1.4
to 5.0 years. Forty-six patients with a HLA-matched donor received a donor marrow
(allogeneic graft) and 45 patients without a matched donor received their own marrow
taken during remission and purged of leukemic cells with the use of monoclonal
antibodies (autologous graft). The survival variable of interest was time to death, in days,
which ranged from 11 to 1845 days. Data contain 22 right-censored observations and
69 uncensored. In general, times to death are longer for allogeneic transplant patients
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(sample median was 292 days) than for autologous patients (sample median was 112
days).
The main goal of the study was to compare both groups, autologous and allogeneic,
with regard to the incidence and the latency models. Covariate information only
contemplates the type of transplant and was incorporated in both terms of the cure model.
Incidence and latency model The cure probability for individual ith corresponding to
the incidence model was expressed in terms of a regression logistic model defined as
logit[ηi(β)] = βAll,1 + βAut,1 IAut(i), (18)
where βAll,1 represents the effect of the reference category, to be an individual who
has received an allogeneic transplant, and IAut(i) is an indicator variable with value 1
whether individual i has had an autologous graft.
Survival time for individual i in the uncured subpopulation, Tui, was modeled by
means of a Weibull AFT model defined as
log(Tui) = βAll,2 + βAut,2 IAut(i) + σ i, (19)
where now βAll,2 represents the effect of receiving an allogeneic graft, and βAut,1 the
additional effect for having an autologous transplant.
The model is completed with the elicitation of a prior distribution for all parameters it
contains. We assume prior independence and select vague normal distributions centered
at zero and variance 1,000 for all the regression coefficients in the model except for
α = 1/σ, for which a Ga(0.01, 0.01) distribution was selected.
Posterior inferences Our algorithm configuration for this model included 20 burn-in
iterations and other 180 for inference. In addition, the simulations were thinned by storing
every 2nd draws in order to reduce autocorrelation in the saved sample. Convergence
was evaluated by examining whether the conditional marginal log-likelihood estimates
achieved stability during the iteration steps of our algorithm.
MCMC simulation was run considering three Markov chains with 200,000 iterations
and a burn-in period with 40,000 iterations. The chains were thinned by storing every
400th iteration to reduce autocorrelation in the saved sample and avoid space computer
problems. Convergence was also here assessed via the potential scale reduction factor
and the effective number of independent simulation draw7. As in the ECOG study, our
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Table 3. Summary of the INLA and MCMC approximate marginal posterior distributions:
mean, standard deviation, 95% credible interval, and posterior probability that the subsequent
parameter is positive.
Parameter Mean Sd 95 %CI P (· > 0)
Incidence INLA βAll,1 -0.988 0.341 [-1.691,-0.351] 0.000
βAut,1 -0.404 0.505 [-1.407,0.575] 0.211
MCMC βAll,1 -1.025 0.355 [-1.763,-0.367] 0.000
βAut,1 -0.413 0.524 [-1.437,0.665] 0.203
Latency INLA βAll,2 -6.372 0.652 [-7.709,-5.131] 0.000
βAut,2 0.759 0.262 [0.247, 1.277] 0.998
α 1.138 0.103 [0.941,1.343] −
MCMC βAll,2 -6.305 0.631 [-7.572,-5.118] 0.000
βAut,2 0.754 0.267 [0.238, 1.287] 1.000
α 1.124 0.101 [0.934,1.325] −
Table 4. Summary of the approximated INLA and MCMC posterior mean, standard deviation,
and 95% credible interval of the cure proportion for allogeneic and autologous graft patients.
Group Mean Sd 95 %CI
INLA All 0.286 0.067 [0.170,0.428]
Aut 0.205 0.060 [0.107,0.342]
MCMC All 0.270 0.067 [0.146,0.410]
Aut 0.198 0.057 [0.094,0.319]
proposed method here also needed less iterations than MCMC configuration to reach
convergence and accurate results.
Table 3 shows the INLA and MCMC mean, standard deviation and 95% credible
interval of the posterior distribution of the cure proportion for allogeneic and autologous
transplant patients. INLA and MCMC results are very similar.
In the case of the estimation of derived quantities of interest, we proceed analogously
to the ECOG study. We estimate the INLA and MCMC posterior distribution for the
cure proportion for allogeneic and autologous transplant patients (Table 4) as well as the
subsequent posterior mean of the uncured survival function (Figure 2). Outcomes also
now present scarce differences and underline that allogeneic transplanted patients seem
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Figure 2. Posterior mean of the uncured survival function for Allogeneic (on the left) and
Autologous (on the right) transplanted patients computed from INLA (black solid line) and
MCMC (red dashed line)
to have cure proportion levels higher than the ones for autologous patients, although we
also appreciate a very broad degree of overlap.
Conclusions
This paper discussed an INLA approach for dealing with mixture cure models based on
a general procedure by2;8;9 that extends INLA to finite mixture models. We introduced
latent indicators in the inferential process for classifying individuals in the cured and
uncured subpopulations, and approximated the relevant posterior distribution via Gibbs
sampling. In particular, we use modal Gibbs sampling8 and INLA to fit the marginal
posterior distribution of each relevant element given the latent indicator variable that
identifies each individual in the cure or uncured population.
Two specific benchmark datasets from the field of medicine have been considered
to illustrate our proposal. In both cases, the results support its viability and good
performance, and almost entirely agree with the MCMC results. Remarkably, our
proposal also shows other interesting properties such as the lower number of iterations
to reach convergence and the convenient exploration of the parametric space of the latent
indicators. Furthermore, the use of INLA to fit conditional models does not force the use
of conjugate priors in the Gibbs sampler and avoids label switchings problems usually
caused by symmetry in the likelihood function of the model parameters32.
On the other hand, MCMC provides, at the moment, slightly faster computational
times and consequently, more research would be necessary to minimize computational
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efforts and storage requirements. Note that INLA estimates two complete models,
incidence and latency, in each iteration. This leads to an important computational burden
because two complete processes in each iteration were generated thus producing new
temporary files and other secondary elements. So, if we limit the default outcomes
provided by INLA and we define prior distributions based on the inferences from the
previous iteration, computational savings could be achieved.
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